J&JI is Johnson & Johnson’s venture capital arm. J&J will receive no board representation as a result of its investment. The companies are currently working to develop tools to diagnose and treat lung cancer. Mauna Kea developed the Cellvizio platform, which can be used to treat an array of conditions, including Barrett’s esophagus. The companies are working to use the Cellvizio platform and the AQ-Flex-19 Confocal Miniprobe to treat lung cancer.
More articles on gastroenterology:
Arkansas health system acquires surgical practice
Work progressing on Quincy Medical Group’s surgery center — 3 insights
UM Shore Regional Health purchases 9+ acres for campus with surgery center — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.